Cargando…
Lovastatin exerts protective effects on endothelial cells via upregulation of PTK2B
Statins are HMG-CoA reductase inhibitors that are used to decrease the blood levels of low-density lipoprotein (LDL). In addition, they have been shown to exert pleiotropic protective effects in the absence of LDL-lowering activity. The present study investigated the effects of lovastatin on global...
Autores principales: | Chu, Weiwei, Guan, Lili, Huang, Dihua, Ren, Yuezhong, Zhou, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998215/ https://www.ncbi.nlm.nih.gov/pubmed/27602089 http://dx.doi.org/10.3892/etm.2016.3547 |
Ejemplares similares
-
Silencing of PTK7 in Colon Cancer Cells: Caspase-10-Dependent Apoptosis via Mitochondrial Pathway
por: Meng, Ling, et al.
Publicado: (2010) -
Lovastatin Alleviates Endothelial-to-Mesenchymal Transition in Glomeruli via Suppression of Oxidative Stress and TGF-β1 Signaling
por: Ma, Zejun, et al.
Publicado: (2017) -
Lovastatin Protects against Experimental Plague in Mice
por: Ayyadurai, Saravanan, et al.
Publicado: (2010) -
Lovastatin upregulates microRNA-29b to reduce oxidative stress in rats with multiple cardiovascular risk factors
por: Wang, Fu, et al.
Publicado: (2017) -
Lovastatin reversed the enhanced sphingomyelin caused by 27-hydroxycholesterol in cultured vascular endothelial cells
por: Zhou, Qi, et al.
Publicado: (2015)